Cetuximab biosimilar is a recombinant monoclonal antibody which binds specifically to the human epidermal growth factor receptor (EGFR). Cetuximab biosimilar interacts with the extracellular region of EGFR to block ligand stimulation and has potent antitumor efficacy. This product is for research use only.
Recommended dilution factor:
Note: Working dilution for specific application should be determined by the investigator to obtain the best conditions.